Thyrocare, Sohrabh Hall, 112, A Wing, 1st Floor, Sangamwadi, Pune - 411 001

PROCESSED AT :
Thyrocare,Sohrabh Hall,
112, A Wing, 1st Floor,
Sangamwadi, Pune – 411 001
NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

REF. BY (30492),NISHKARSH CLINICAL LABORATORY,IN
: SELF
FRONT OF ADARSH PATSANSTHA, NEAR
TEST ASKED : AAROGYAM B PRO MAHENDRA GENTS SALON, WING HOTEL, KARAD,
SATARA. 9822551835,415110
TEST NAME TECHNOLOGY VALUE UNITS
IRON PHOTOMETRY 37.4 µg/dl

Reference Range :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 547 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 6.84 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
Please correlate with clinical conditions.
Sample Collected on (SCT) : 17 Jan 2022 14:30
Sample Received on (SRT) : 18 Jan 2022 03:25

Report Released on (RRT) : 18 Jan 2022 05:51
Sample Type : SERUM
Labcode : 1701095009/PU117 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Barcode : T6722859
Page : 1 of 9
PROCESSED AT :

REF. BY (30492),NISHKARSH CLINICAL LABORATORY,IN FRONT
: SELF
OF ADARSH PATSANSTHA, NEAR MAHENDRA GENTS
TEST ASKED : AAROGYAM B PRO SALON, WING HOTEL, KARAD, SATARA.
9822551835,415110
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE

TOTAL CHOLESTEROL PHOTOMETRY 211 mg/dl < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 50 mg/dl 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 147 mg/dl < 100
TRIGLYCERIDES PHOTOMETRY 129 mg/dl < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.2 Ratio 3-5
LDL / HDL RATIO CALCULATED 2.9 Ratio 1.5-3.5
NON-HDL CHOLESTEROL CALCULATED 160.56 mg/dl < 160
VLDL CHOLESTEROL CALCULATED 25.8 mg/dl 5 - 40
Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
LDL - DIRECT MEASURE
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500

VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM
Barcode : T6722859 Page : 2 of 9
PROCESSED AT :

: SELF
9822551835,415110

ALKALINE PHOSPHATASE PHOTOMETRY 114 U/L 45 - 129
BILIRUBIN - TOTAL PHOTOMETRY 0.72 mg/dl 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.22 mg/dl < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.5 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 16 U/l < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 25 U/l < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 24.67 U/l < 34
PROTEIN - TOTAL PHOTOMETRY 7.26 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.32 gm/dl 3.2-4.8
SERUM GLOBULIN PHOTOMETRY 2.94 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.47 Ratio 0.9 - 2
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM
PROCESSED AT :

: SELF
9822551835,415110

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.2 mg/dl 7 - 25
CREATININE - SERUM PHOTOMETRY 0.62 mg/dl 0.5-0.8
BUN / SR.CREATININE RATIO CALCULATED 14.84 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 10.3 mg/dl 8.8-10.6
URIC ACID PHOTOMETRY 5.5 mg/dl 3.2 - 6.1
SODIUM I.S.E 142 mmol/l 136 - 145
POTASSIUM I.S.E 4.3 mmol/l 3.5 - 5.1
CHLORIDE I.S.E 108 mmol/l 98 - 107
Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD
SOD - ION SELECTIVE ELECTRODE
POT - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Type : SERUM
PROCESSED AT :

(30492),NISHKARSH CLINICAL LABORATORY,IN FRONT
REF. BY : SELF
9822551835,415110
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 119 ng/dl 60-200

TOTAL THYROXINE (T4) C.L.I.A 8 µg/dl 4.5-12
THYROID STIMULATING HORMONE (TSH) C.L.I.A 2.04 µIU/ml 0.3-5.5
Comments : SUGGESTING THYRONORMALCY

Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY
Pregnancy reference ranges for TSH
1st Trimester : 0.10 - 2.50
2nd Trimester : 0.20 - 3.00
3rd Trimester : 0.30 - 3.00
Reference:
Guidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During
Pregnancy and Postpartum, Thyroid, 2011, 21; 1-46

Sample Type : SERUM
PROCESSED AT :

REF. BY : SELF (30492),NISHKARSH CLINICAL LABORATORY,IN
FRONT OF ADARSH PATSANSTHA, NEAR MAHENDRA
TEST ASKED : AAROGYAM B PRO GENTS SALON, WING HOTEL, KARAD, SATARA.
9822551835,415110

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 109 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.
Method:- CKD-EPI Creatinine Equation

Sample Type : SERUM
Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)
Labcode : 1701095009/PU117
PROCESSED AT :

REF. BY (30492),NISHKARSH CLINICAL LABORATORY,IN
: SELF
TEST ASKED : HbA1c,HEMOGRAM MAHENDRA GENTS SALON, WING HOTEL, KARAD,
SATARA. 9822551835,415110

HbA1c - (HPLC)
H.P.L.C 6.3 %
Reference Range :
Reference Range: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C. using Biorad Variant II Turbo
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 134 mg/dl
Reference Range :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values

Sample Type : EDTA
Barcode : X0960520
Page : 7 of 9
PROCESSED AT :

REF. BY : SELF (30492),NISHKARSH CLINICAL LABORATORY,IN
TEST ASKED : HbA1c,HEMOGRAM
MAHENDRA GENTS SALON, WING HOTEL,
KARAD, SATARA. 9822551835,415110
TEST NAME VALUE UNITS REFERENCE RANGE

TOTAL LEUCOCYTES COUNT 6.07 X 10³ / µL 4.0-10.0
NEUTROPHILS 59.9 % 40-80
LYMPHOCYTE PERCENTAGE 33.9 % 20.0-40.0
MONOCYTES 3.1 % 0.0-10.0
EOSINOPHILS 2.6 % 0.0-6.0
BASOPHILS 0.2 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT 3.64 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 2.06 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.19 X 10³ / µL 0.2-1.0
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0.02-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.16 X 10³ / µL 0.02-0.5
IMMATURE GRANULOCYTES(IG) 0.02 X 10³ / µL 0.0-0.3
TOTAL RBC 5.06 X 10^6/µL 3.9-4.8
NUCLEATED RED BLOOD CELLS Nil X 10³ / µL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 11.2 g/dL 12.0-15.0
HEMATOCRIT(PCV) 38.4 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) 75.9 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 22.1 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 29.2 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 46.2 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 16.8 % 11.6-14.0
PLATELET DISTRIBUTION WIDTH(PDW) 15.5 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 11.9 fL 6.5-12
PLATELET COUNT 333 X 10³ / µL 150-400
PLATELET TO LARGE CELL RATIO(PLCR) 41.1 % 19.7-42.4
PLATELETCRIT(PCT) 0.4 % 0.19-0.39
Remarks : ALERT !!! Hypochromia
Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow
Cytometry Method (using a semiconductor laser), and SLS- hemoglobin method)
~~ End of report ~~

Sample Type : EDTA
Barcode : X0960520 Page : 8 of 9
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950851,8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 9 of 9

Thyrocare, Sohrabh Hall, 112, A Wing, 1st Floor, Sangamwadi, Pune - 411 001

Uploaded by

Copyright:

Available Formats

Thyrocare, Sohrabh Hall, 112, A Wing, 1st Floor, Sangamwadi, Pune - 411 001

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Thyrocare, Sohrabh Hall, 112, A Wing, 1st Floor, Sangamwadi, Pune - 411 001

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 37.4 µg/dl

Sample Collected on (SCT) : 17 Jan 2022 14:30

Sample Received on (SRT) : 18 Jan 2022 03:25

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

Sample Collected on (SCT) : 17 Jan 2022 14:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE

Sample Collected on (SCT) : 17 Jan 2022 14:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE

Sample Collected on (SCT) : 17 Jan 2022 14:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE

TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 119 ng/dl 60-200

Comments : SUGGESTING THYRONORMALCY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 17 Jan 2022 14:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Sample Collected on (SCT) : 17 Jan 2022 14:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME TECHNOLOGY VALUE UNITS

Reference Range: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 17 Jan 2022 14:30

Sample Received on (SRT) : 18 Jan 2022 03:30

NAME : MRS VIDYA G GHATAGE (45Y/F) SAMPLE COLLECTED AT :

TEST NAME VALUE UNITS REFERENCE RANGE

Please Correlate with clinical conditions.

Sample Collected on (SCT) : 17 Jan 2022 14:30

You might also like